Gefen Biomed Investment is an investment company in the field of life sciences, primarily active in the medical devices, cleantech and biotechnology sectors.
Gefen is traded in the Tel Aviv Stock Exchange. Gefen’s risk management is done through leverage of government funding of OCS’ Incubator Program and additional programs. The company accumulated significant experience in portfolio management, technology transfer from universities and establishing spin-offs. It owns two technology incubators -ATI-Ashkelon incubator (100%) and Meytav-Tel Hay incubator (85%).